Finance fibrillation and research rhythm: Do we need a pacemaker?

Journal of Ambulatory Care Management

Volumn 31, Issue 2, 2008, Pages 187-189

  Apolone, Giovanni ^a   Patarnello, Francesca ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b GSK   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; DRUG APPROVAL; DRUG INDUSTRY; ECONOMICS; HUMAN; REIMBURSEMENT; UNITED STATES;

DRUG APPROVAL; DRUG INDUSTRY; HUMANS; PHARMACEUTICAL PREPARATIONS; REIMBURSEMENT MECHANISMS; UNITED STATES;

EID: 41149112014     PISSN: 01489917     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.JAC.0000314709.65289.72     Document Type: Article

References (4)

1. Apolone, G., & Patarnello, F. (2008). The Value of a Drug: From Innovation to the Payment via Karl Marx. J Ambul Care Manage, 31(1), 52-55.
2. Aronson, J. K. (2008). Something new every day: Defining innovation and innovativeness in drug therapy. J Ambul Care Manage, 37(1), 65-68.
3. Cesario, A. (2008). Commentary on Giovanni Apolone's "The Value of a Drug: From Innovation to the Payment via Karl Marx" .J. Ambul Care Manage, 31(1), 61-64.
4. Reinhardt, UE. (2008). Commentary on Giovanni Apolone's "The Value of a Drug: From Payment to the National Health Service via Karl Marx" .J Ambul Care Manage, 37(1), 56-60.